Novel cholesteryl ester transfer protein inhibitors: promising therapy for dyslipidemia?

Metab Syndr Relat Disord. 2011 Jun;9(3):163-5. doi: 10.1089/met.2011.1500. Epub 2011 May 10.
No abstract available

Publication types

  • Editorial
  • Evaluation Study

MeSH terms

  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / therapeutic use*
  • Dyslipidemias / drug therapy*
  • Humans
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / therapeutic use
  • Molecular Targeted Therapy / adverse effects
  • Molecular Targeted Therapy / methods
  • Oxazolidinones / adverse effects
  • Oxazolidinones / pharmacology
  • Oxazolidinones / therapeutic use
  • Quinolines / adverse effects
  • Quinolines / pharmacology
  • Quinolines / therapeutic use

Substances

  • Cholesterol Ester Transfer Proteins
  • Drugs, Investigational
  • Hypolipidemic Agents
  • Oxazolidinones
  • Quinolines
  • torcetrapib
  • anacetrapib